Market-Moving News for December 18th
Market-Moving News for December 18th
12月18日的市場動向資訊
PLRZ: 282% | Polyrizon Secures GMP Manufacturing Partnership With Eurofins CDMO Amatsiaquitaine, Advancing Toward PL-14 Allergy Blocker Clinical Trial In 2025
PLRZ: 282% | Polyrizon與Eurofins CDMO Amatsiaquitaine達成GMP製造合作伙伴關係，朝着2025年的PL-14過敏阻斷臨床試驗邁進
CRVS: 24% | Corvus Pharmaceuticals shares are trading higher after the company announced it will report on December 18 interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.
CRVS: 24% | Corvus Pharmaceuticals的股票在公司宣佈將在12月18日公佈其對中度至重度特應性皮炎患者進行的Soquelitinib一期臨床試驗的中期數據後上漲
OKLO: 10% | Oklo And Switch Partner To Deploy 12 GW Of Advanced Nuclear Power
OKLO: 10% | Oklo與交換機-雲計算合作，部署12GW的愛文思控股核電
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間